Regenicin, Inc.
RGIN · OTC
9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $601 | $0 | $0 | $0 |
| Gross Profit | -$601 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $601 | $842 | $664 | $737 |
| SG&A Expenses | $601 | $842 | $664 | $737 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$207 | -$153 | $0 |
| Operating Expenses | $601 | $636 | $511 | $737 |
| Operating Income | -$601 | -$636 | -$511 | -$737 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$38 | -$35 | -$49 | -$22 |
| Pre-Tax Income | -$639 | -$671 | -$560 | -$758 |
| Tax Expense | $0 | $0 | $0 | $18 |
| Net Income | -$639 | -$671 | -$560 | -$758 |
| % Margin | – | – | – | – |
| EPS | -0.005 | -0.005 | -0.004 | -0.005 |
| % Growth | 6.2% | -17.1% | 19.6% | – |
| EPS Diluted | -0.005 | -0.005 | -0.004 | -0.005 |
| Weighted Avg Shares Out | 153,483 | 153,483 | 153,483 | 153,483 |
| Weighted Avg Shares Out Dil | 153,483 | 153,483 | 153,483 | 153,483 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $36 | $35 | $47 | $18 |
| Depreciation & Amortization | $2 | $0 | $206 | $172 |
| EBITDA | -$601 | -$636 | -$511 | -$737 |
| % Margin | – | – | – | – |